Metallo-beta-lactamases (MBLs) contribute to the resistance of Gram-negative bacteria to carbapenems, last-resort antibiotics at hospital, and MBL inhibitors are urgently needed to preserve these important antibacterial drugs. Here, we describe a series of 1,2,4-triazole-3-thione-based inhibitors displaying an alpha-amino acid substituent, which amine was mono- or disubstituted by (hetero)aryl groups. Compounds disubstituted by certain nitrogencontaining heterocycles showed submicromolar activities against VIM-type enzymes and strong NDM-1 inhibition (K-i = 10-30 calorimetry (ITC), and X-ray crystallography showed that the compounds inhibited both VIM-2 and NDM-1 at least partially by stripping the catalytic zinc ions. These inhibitors also displayed a very potent synergistic activity with meropenem (16- to 1000-fold minimum inhibitory concentration (MIC) reduction) against VIM-type- and NDM-1-producing ultraresistant clinical isolates, including Enterobacterales and Pseudomonas aeruginosa. Furthermore, selected compounds exhibited no or moderate toxicity toward HeLa cells, favorable absorption, distribution, metabolism, excretion (ADME) properties, and no or modest inhibition of several mammalian metalloenzymes.
Legru, A., Verdirosa, F., Vo-Hoang, Y., Tassone, G., Vascon, F., Thomas, C.A., et al. (2022). Optimization of 1,2,4-Triazole-3-thiones toward Broad-Spectrum Metallo-β-lactamase Inhibitors Showing Potent Synergistic Activity on VIM- and NDM-1-Producing Clinical Isolates. JOURNAL OF MEDICINAL CHEMISTRY, 65(24), 16392-16419 [10.1021/acs.jmedchem.2c01257].
Optimization of 1,2,4-Triazole-3-thiones toward Broad-Spectrum Metallo-β-lactamase Inhibitors Showing Potent Synergistic Activity on VIM- and NDM-1-Producing Clinical Isolates
Tassone, Giusy;Sannio, Filomena;Benvenuti, Manuela;Marcoccia, Francesca;Devente, Savannah Rowane;Pozzi, Cecilia;Mangani, Stefano;Docquier, Jean-Denis
;
2022-01-01
Abstract
Metallo-beta-lactamases (MBLs) contribute to the resistance of Gram-negative bacteria to carbapenems, last-resort antibiotics at hospital, and MBL inhibitors are urgently needed to preserve these important antibacterial drugs. Here, we describe a series of 1,2,4-triazole-3-thione-based inhibitors displaying an alpha-amino acid substituent, which amine was mono- or disubstituted by (hetero)aryl groups. Compounds disubstituted by certain nitrogencontaining heterocycles showed submicromolar activities against VIM-type enzymes and strong NDM-1 inhibition (K-i = 10-30 calorimetry (ITC), and X-ray crystallography showed that the compounds inhibited both VIM-2 and NDM-1 at least partially by stripping the catalytic zinc ions. These inhibitors also displayed a very potent synergistic activity with meropenem (16- to 1000-fold minimum inhibitory concentration (MIC) reduction) against VIM-type- and NDM-1-producing ultraresistant clinical isolates, including Enterobacterales and Pseudomonas aeruginosa. Furthermore, selected compounds exhibited no or moderate toxicity toward HeLa cells, favorable absorption, distribution, metabolism, excretion (ADME) properties, and no or modest inhibition of several mammalian metalloenzymes.File | Dimensione | Formato | |
---|---|---|---|
acs.jmedchem.2c01257.pdf
non disponibili
Descrizione: Full text
Tipologia:
PDF editoriale
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
8.32 MB
Formato
Adobe PDF
|
8.32 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Optimization of 1 2 4-Triazole-3-thiones-Legru-2022-PPrint.pdf
Open Access dal 24/12/2023
Descrizione: Manuscript
Tipologia:
Post-print
Licenza:
PUBBLICO - Pubblico con Copyright
Dimensione
7.31 MB
Formato
Adobe PDF
|
7.31 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/1244855